# Evaluation of Lung Function and Symptoms in Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD) on Long-Acting Bronchodilator Monotherapy

> **NCT00791518** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 1084 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** No intervention

## Key facts

- **NCT ID:** NCT00791518
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 1084 (ACTUAL)
- **Last updated:** 2014-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00791518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00791518, "Evaluation of Lung Function and Symptoms in Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD) on Long-Acting Bronchodilator Monotherapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00791518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*